CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.92 +0.02 (+2.23%)
At close: Oct 2, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Depreciation & Amortization - Total (2025 - 2026)

Updated

CytoMed Therapeutics (GDTC) recorded Depreciation & Amortization - Total of $88,024 in Q2 2026, up 4.2% from $84,490 a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Depreciation & Amortization - Total (2025 - 2026) Analysis & Trends

For FY2025, CytoMed Therapeutics reported Depreciation & Amortization - Total of -$196,896.

  • Across earlier years, Depreciation & Amortization - Total came in at -$109,842 in FY2024, -$101,866 in FY2023, -$109,246 in FY2022 and -$98,721 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn -
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn -
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 CytoMed Therapeutics 10.65 Mn -437,065.76 - 88,024.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 88,024.00
Jun 30, 2025 84,490.00
API Access

CytoMed Therapeutics Depreciation & Amortization - Total API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-total&ticker=GDTC&period=max&api_key=YOUR_API_KEY